Mladsi D, Zhou X, Mader G, Sanon M, Wang J, Barnett C, Willey C, Seliger S. Mortality risk in patients with autosomal dominant polycystic kidney disease. BMC Nephrol. 2024 Feb 16;25(1):56. doi: 10.1186/s12882-024-03484-3
Danese D, Goss D, Romano (DeMuro) C, Gupta C. Qualitative assessment of the patient experience of primary hyperoxaluria type 1: an observational study. BMC Nephrol. 2023 Oct 26;24(1):319. doi: 10.1186/s12882-023-03365-1
Mader G, Mladsi D, Sanon M, Purser M, Barnett CL, Oberdhan D, Watnick T, Seliger S. A disease progression model estimating the benefit of tolvaptan on time to end-stage renal disease for patients with rapidly progressing autosomal dominant polycystic kidney disease. BMC Nephrol. 2022 Oct 18;23(1):334. doi: 10.1186/s12882-022-02956-8
Moran D, Juliao P, Alvarez D, Lindblade KA, Ellison JA, Gilbert AT, Petersen B, Rupprecht C, Recuenco S. Knowledge, attitudes and practicesregarding rabies and exposure to bats in two rural communities in Guatemala. BMC Res Notes. 2015 Jan 10;8:955. doi: 10.1186/s13104-014-0955-1
Bayer AM, Danysh HE, Garvich M, Gonzalvez G, Checkley W, Alvarez M, Gilman RH. An unforgettable event: a qualitative study of the 1997-98 El Niño in northern Peru. Disasters. 2014 Apr;38(2):351-74. doi: 10.1111/disa.12046
Sabate M, Pacheco JF, Ballarín E, Ferrer P, Petri H, Hasford J, Schoonen MW, Rottenkolber M, Fortuny J, Laporte JR, Ibanez L. A compilation of research working groups on drug utilisation across Europe. BMC Res Notes. 2014;7:143.
Viera AJ, Edwards T. Does an offer for a free on-line continuing medical education (CME) activity increase physician survey response rate? A randomized trial. BMC Res Notes. 2012 Mar 7;5:129. doi: 10.1186/1756-0500-5-129
Soler-Gonzalez J, Ruiz C, Serna C, Marsal JR. The profile of general practitioners (GPs) who publish in selected family practice journals. BMC Res Notes. 2011 May 26;4:164. doi: 10.1186/1756-0500-4-164